Results 1 to 10 of about 40,585 (248)

Development of the Swedish anticholinergic burden scale (Swe-ABS)

BMC Geriatrics, 2023
Background Drugs with anticholinergic properties are associated with cognitive adverse effects, especially in patients vulnerable to central muscarinic antagonism. A variety of drugs show weak, moderate or strong anticholinergic effects.
Tanja Rube, Astrid Ecorcheville, Elisabet Londos, Sara Modig, Per Johansson   +4 more
doaj   +2 more sources

Measuring cumulative anticholinergic medicines burden in older Australian women [PDF]

International Journal of Population Data Science, 2017
Objectives Anticholinergic medicines burden is common, can have negative impacts, and is problematic to identify. Many medicines used by older women have anticholinergic effects.
Lynne Parkinson, Parker Magin, Tkt Lo, Julie Byles, Rachael Moorin   +4 more
doaj   +2 more sources

Anticholinergic burden in community-dwelling older adults: prevalence, associated factors, and agreement between measurement scales [PDF]

Frontiers in Pharmacology
AimAssessing cumulative anticholinergic exposure is essential in geriatric pharmacotherapy and medication safety. The present study aimed to provide real-world evidence on this issue in community-dwelling older adults.
Francisco De Borja Rodríguez-Salas, María Angeles Merchán-Cruz, Ricardo Ocaña-Riola, Pilar María Díez-de-Baldeón-Chicón, José Pablo Lara, José Pablo Lara, Encarnación Blanco-Reina, Encarnación Blanco-Reina   +7 more
doaj   +2 more sources

Anticholinergic Medication Burden in Parkinson’s Disease Outpatients

Journal of Parkinson’s Disease, 2022
Background: Individuals with Parkinson’s disease (PD) may be especially vulnerable to future cognitive decline from anticholinergic medications. Objective: To characterize anticholinergic medication burden, determine the co-occurrence of anticholinergic ...
Huma Nawaz, Lana Sargent, Helengrace Quilon, Leslie J. Cloud, Claudia M. Testa, Jon D. Snider, Sarah K. Lageman, Mark S. Baron, Brian D. Berman, Kristin Zimmerman, Elvin T. Price, Nitai D. Mukhopadhyay, Matthew J. Barrett   +12 more
doaj   +1 more source

Anti-Cholinergic Drug Burden Among Ambulatory Elderly Patients in a Nigerian Tertiary Healthcare Facility

Frontiers in Pharmacology, 2021
Background: The use of drugs with anticholinergic effects among elderly patients is associated with adverse clinical outcomes. There is paucity of information about anticholinergic drug burden among Nigerian elderly population.Objectives: To determine ...
Joseph O. Fadare, Joseph O. Fadare, Abimbola Margaret Obimakinde, Abimbola Margaret Obimakinde, Felix O. Aina, Ebisola J. Araromi, Theophilus Adekunle Adegbuyi, Oluwatoba E. Osasona, Tosin A. Agbesanwa   +8 more
doaj   +1 more source

A meta-analysis of observational studies on anticholinergic burden and fracture risk: evaluation of conventional burden scales

Journal of Pharmaceutical Health Care and Sciences, 2021
Background Anticholinergic burden potentially increases the risk of fracture. Although there are various anticholinergic burden scales, little is known about the inter-scale compatibility regarding the relationship of anticholinergic burden with fracture
Yukari Ogawa, Toshinori Hirai, Kiyoshi Mihara   +2 more
doaj   +1 more source

Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review

BMC Pharmacology and Toxicology, 2022
Purpose The aim of this work was to investigate the association between anticholinergic burden or anticholinergic drug use and xerostomia and/or xerophtalmia in elderly through a systematic review of the published literature. Methods A search was carried
E. Prado-Mel, P. Ciudad-Gutiérrez, H. Rodríguez-Ramallo, S. Sánchez-Fidalgo, B. Santos-Ramos, A. M. Villalba-Moreno   +5 more
doaj   +1 more source

Identification of anticholinergic activity of drugs of the Brazilian National List of Essential Drugs

Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2020
Objectives: Identify drugs from the National List of Essential Medicines-Rename 2018 that have anticholinergic activity and scales of anticholinergic activity available for use in clinical practice.
Mariana S. LIMA, Adriano M. REIS
doaj   +1 more source

Postablation and α-1 blocker therapy in children with congenital obstructing posterior urethral membrane

Formosan Journal of Surgery, 2021
Background: Congenital obstructing posterior urethral membrane (COPUM) or posterior urethral valve (PUV) is the most common cause of lower urinary tract obstruction in boys.
Minu Bajpai, Aejaz Baba, Amit Kumar Singh   +2 more
doaj   +1 more source

Anticholinergic Drug Exposure Increases the Risk of Delirium in Older Patients Undergoing Elective Surgery

Frontiers in Medicine, 2022
IntroductionPostoperative delirium (POD) is a common and serious adverse event of surgery in older people. Because of its great impact on patients' safety and quality of life, identification of modifiable risk factors could be useful.
Matthias L. Herrmann, Matthias L. Herrmann, Cindy Boden, Christoph Maurer, Christoph Maurer, Felix Kentischer, Eva Mennig, Sören Wagner, Sören Wagner, Lars O. Conzelmann, Bernd R. Förstner, Michael A. Rapp, Christine A. F. von Arnim, Michael Denkinger, Michael Denkinger, Gerhard W. Eschweiler, Christine Thomas, Christine Thomas   +17 more
doaj   +1 more source